SEPSIS PATHOGENS AND ANTIBIOTIC RESISTANCE IN THONG NHAT HOSPITAL
Article Information
Download Article
How to Cite
Abstract
This study investigates the distribution of pathogenic microorganisms and their antibiotic resistance status in bloodstream infections at Thong Nhat Hospital from April 30, 2024, to May 1, 2025. Retrospective, cross-sectional descriptive study conducted on 770 microbial isolates obtained from blood samples from April 30, 2024, to May 1, 2025, at Thong Nhat Hospital. Among the total 770 isolated strains, bacteria accounted for 97.27%, and fungi accounted for 2.73%. The common pathogens included Coagulase-negative Staphylococci (30.44%), Escherichia coli (21.23%), Staphylococcus aureus (8.54%), Klebsiella pneumoniae (7.34%), and Pseudomonas aeruginosa (2.94%). E. coli showed >80% susceptibility to amikacin and piperacillin/tazobactam and >97% susceptibility to carbapenems. K. pneumoniae demonstrated resistance rates of 30.2% to imipenem, 31,3% to meropenem, and 25.5% to ertapenem. P. aeruginosa resistance rates were 50% to imipenem and 40.9% to meropenem. S. aureus exhibited high resistance to benzylpenicillin (96.6%), erythromycin (75.9%), and clindamycin (67.2%) but remained 100% susceptible to vancomycin, linezolid, teicoplanin, and tigecycline. The MRSA rate was 62.5%. Candida spp. remained susceptible to commonly used antifungal agents. Bacteria are the primary cause of bloodstream infections. Multidrug-resistant strains such as P. aeruginosa, K. pneumoniae, and MRSA account for a significant proportion. Continuous monitoring of resistance patterns supports clinicians in selecting appropriate antibiotics, thereby reducing mortality and treatment costs.
Keywords
References
- Singer M et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
- Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
- Bùi Thị Vân Nga, Vũ Hường Thị, et al. Nghiên cứu đặc điểm các tác nhân gây nhiễm khuẩn huyết tại Viện Huyết học - Truyền máu Trung ương năm 2015. Tạp chí Y học Việt Nam. 2016;446:289-296.
- Nguyễn Ngọc Lân. Các tác nhân nhiễm khuẩn huyết và tình hình đề kháng kháng sinh tại Bệnh viện Thống Nhất. 2023.
- Bộ Y tế. Kế hoạch hành động quốc gia về chống kháng thuốc. 2013;trang 1-29.
- Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0.
- Wan Muhd Shukeri WF, Mat Nor MB, Md Ralib A. Sepsis and Its Impact on Outcomes in Elderly Patients Admitted to a Malaysian Intensive Care Unit. Malays J Med Sci. 2022;29:145–150.
- Hayakawa M, Saito S, Uchino S, et al. Characteristics, treatments, and outcomes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011-2013. Journal of Intensive Care. 2016;4(44). doi: 10.1186/s40560-016-0169-9.
- Fungal Infections. Sepsis Alliance. December 2017.
- Dat Vu Quoc, Vu Hieu Ngoc, et al. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome. BMC Infect Dis. 2017;17(1):493.
- Nguyen Van Kinh et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013;13:1158.
- GARP-Việt Nam national working group. Situation analysis on antibiotic use and resistance in Vietnam. 2010.
License
© 2025 Journal of Health and Aging - Thong Nhat Hospital

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.